Compounds > 3-iodobenzylguanidine
Page last updated: 2024-08-24

3-iodobenzylguanidine and FMR1-Related Primary Ovarian Insufficiency

3-iodobenzylguanidine has been researched along with FMR1-Related Primary Ovarian Insufficiency in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clement, SC; Kraal, KC; Kremer, LC; Tytgat, GA; van den Bos, C; van Eck-Smit, BL; van Santen, HM1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and FMR1-Related Primary Ovarian Insufficiency

ArticleYear
Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
    The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:1

    Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Child; Female; Humans; Iodine Radioisotopes; Neuroblastoma; Primary Ovarian Insufficiency; Radiation Injuries; Spinal Cord Compression; Spinal Neoplasms

2014